Asia PacificBreaking News

J&J, Sanofi led $10 M funding raised by pharmaceutical platform SwipeRx

Sanofi Global Health Unit and Cercano Management have invested $10 million in SwipeRx, a pharmaceutical platform with its headquarters in Singapore. SIG, Johnson & Johnson, and Patamar Capital, who are already investors, also took part.

Farouk Meralli founded SwipeRx in 2014, a platform that links more than 50,000 pharmacies and 250,000 business professionals throughout Southeast Asia. It offers users information to help them run pharmacies and better serve patients, in addition to B2B commerce options.

To link the whole pharmaceutical ecosystem, the company collaborates with pharmaceutical firms, governments, and non-governmental groups.

The additional money will be used by SwipeRx to develop its e-commerce platform and drugstore network.

The firm secured US $27 million in a series B investment in May 2022, with the Bill & Melinda Gates Foundation and other investors joining MDI Ventures of Indonesia.




Related Articles

Back to top button